Consider HIV a CV "Risk Enhancer"
August 2019
Better antiretroviral therapy means more patients living with HIV will face dyslipidemia and CV disease.
HIV itself increases CV risk...possibly by triggering inflammatory mediators linked to atherosclerosis or platelet activation.
Consider nuances to managing CV risk in patients living with HIV.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote